- Profile
- Personal Information
- Publications
Experts in Pharmaceutical Sciences
Rabaa M. Al-Rousan Hamed I. Aly Daniela Z. Bazan Adam Brown Wei Minjie Juan F. Castro Dr. Manoj Kumar Barthwal Dr Jagavelu Kumaravelu Zakaria Abd Elmageed Burton M Altura BENJAMIN E. BLASS Charlotte Farris Michael Borenstein prof. dr. A.J.R. Heck Vibha Rani Reza Fassihi Shweta Dang MARC ILIES Adriana Ribeiro Silva SWATI NAGAR View MoreDr.Piet Wigerinck
Chief Executive Officer
Pharmaceutical
Galapagos
France
Piet Wigerinck joined Galapagos in April 2008 from Tibotec (a subsidiary of Johnson & Johnson) where he was VP Drug Discovery, Early Development and CM&C, and a member of the Management Board. He started his professional career as a medicinal chemist at Janssen Research Foundation in 1992. He then joined Tibotec in 1998, where, under his leadership, TMC114 (PrezistaTM) was selected and moved forward into clinical trials. Dr. Wigerinck also played a key role in Tibotec’s expansion into novel diseases such as Hepatitis C and advanced several compounds into Phase 1 and Phase 2 clinical trials. He brings over 15 years of research and development experience from both big pharma and biotech to Galapagos. Piet Wigerinck holds a PhD from the K.U. Leuven and is inventor on more than 25 patent applications.
Worked for discovering novel drugs for diseases like Hepatitis C and has many patents in drug discovery based on research experience.